MXPA05010433A - Derivados de pirrolidina y procedimiento para prepararlos. - Google Patents

Derivados de pirrolidina y procedimiento para prepararlos.

Info

Publication number
MXPA05010433A
MXPA05010433A MXPA05010433A MXPA05010433A MXPA05010433A MX PA05010433 A MXPA05010433 A MX PA05010433A MX PA05010433 A MXPA05010433 A MX PA05010433A MX PA05010433 A MXPA05010433 A MX PA05010433A MX PA05010433 A MXPA05010433 A MX PA05010433A
Authority
MX
Mexico
Prior art keywords
pyrrolidine
amide
phenyl
derivatives
production
Prior art date
Application number
MXPA05010433A
Other languages
English (en)
Spanish (es)
Inventor
Gleitz Johannes
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10315377A external-priority patent/DE10315377A1/de
Priority claimed from DE10327428A external-priority patent/DE10327428A1/de
Priority claimed from DE2003129295 external-priority patent/DE10329295A1/de
Priority claimed from DE2003134174 external-priority patent/DE10334174A1/de
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of MXPA05010433A publication Critical patent/MXPA05010433A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MXPA05010433A 2003-04-03 2004-03-09 Derivados de pirrolidina y procedimiento para prepararlos. MXPA05010433A (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE10315377A DE10315377A1 (de) 2003-04-03 2003-04-03 Carbonylverbindungen
DE10327428A DE10327428A1 (de) 2003-06-18 2003-06-18 Ethinylprolinderivate
DE2003129295 DE10329295A1 (de) 2003-06-30 2003-06-30 Carbonylverbindungen
DE10329457A DE10329457A1 (de) 2003-04-03 2003-07-01 Ethinylprolinderivate
DE2003134174 DE10334174A1 (de) 2003-07-26 2003-07-26 Pyrrolidinderivate und Verfahren zur Herstellung
PCT/EP2004/002405 WO2004087695A1 (de) 2003-04-03 2004-03-09 Verfahren zur herstellung von pyrrolidin-1,2-dicarbonsäure-1-(phenyl(-amid))-2-(phenyl(-amid)) derivaten und 1-(phenylcarbamoyl)-pyrrolidin-2-carbonsäure derivate als zwischenprodukte

Publications (1)

Publication Number Publication Date
MXPA05010433A true MXPA05010433A (es) 2005-11-04

Family

ID=33136213

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010433A MXPA05010433A (es) 2003-04-03 2004-03-09 Derivados de pirrolidina y procedimiento para prepararlos.

Country Status (16)

Country Link
US (1) US7504500B2 (enExample)
EP (1) EP1608646B1 (enExample)
JP (1) JP4634369B2 (enExample)
KR (1) KR20050118709A (enExample)
AR (1) AR043831A1 (enExample)
AT (1) ATE366732T1 (enExample)
AU (1) AU2004226280B2 (enExample)
BR (1) BRPI0408888A (enExample)
CA (1) CA2520893C (enExample)
DE (2) DE10329457A1 (enExample)
ES (1) ES2287708T3 (enExample)
MX (1) MXPA05010433A (enExample)
PE (1) PE20050395A1 (enExample)
PL (1) PL377138A1 (enExample)
TW (1) TW200500339A (enExample)
WO (1) WO2004087695A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050119266A1 (en) * 2003-10-01 2005-06-02 Yan Shi Pyrrolidine and piperidine derivatives as factor Xa inhibitors
DE102004004731A1 (de) * 2004-01-30 2005-08-18 Merck Patent Gmbh Harnstoffderivate
DE102004045796A1 (de) * 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
DE102004047254A1 (de) * 2004-09-29 2006-04-13 Merck Patent Gmbh Carbonylverbindungen
DE102004050283A1 (de) * 2004-10-15 2006-04-27 Lanxess Deutschland Gmbh 4-Aminophenyl-morpholinon-Derivate und deren Herstellung
US7301817B2 (en) * 2005-10-27 2007-11-27 Sandisk Corporation Method for programming of multi-state non-volatile memory using smart verify
EP1951717A1 (en) * 2005-11-16 2008-08-06 F.Hoffmann-La Roche Ag Novel pyrrolidine derivatives as inhibitors of coagulation factor xa
EP1818330A1 (de) * 2006-02-14 2007-08-15 Boehringer Ingelheim Pharma GmbH & Co.KG Substituierte Prolinamide, deren Herstellung und deren Verwendung als Arzneimittel
PE20080702A1 (es) 2006-05-16 2008-07-10 Boehringer Ingelheim Int PROLINAMIDAS SUSTITUIDAS COMO INHIBIDORES DEL FACTOR Xa
US8673920B2 (en) * 2009-05-06 2014-03-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2012058116A1 (en) 2010-10-27 2012-05-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2012058134A1 (en) 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
CN103874493A (zh) 2011-08-19 2014-06-18 默沙东公司 肾外髓质钾通道的抑制剂
EP2755656B1 (en) 2011-09-16 2016-09-07 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2771005B1 (en) 2011-10-25 2016-05-18 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2013062900A1 (en) 2011-10-25 2013-05-02 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9139585B2 (en) 2011-10-31 2015-09-22 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
EP2773351B1 (en) 2011-10-31 2017-08-23 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
US9108947B2 (en) 2011-10-31 2015-08-18 Merck Sharp & Dohme Corp. Inhibitors of the Renal Outer Medullary Potassium channel
US9206199B2 (en) 2011-12-16 2015-12-08 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
AR092031A1 (es) 2012-07-26 2015-03-18 Merck Sharp & Dohme Inhibidores del canal de potasio medular externo renal
US9777002B2 (en) 2012-11-29 2017-10-03 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2934533B1 (en) 2012-12-19 2017-11-15 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2014126944A2 (en) 2013-02-18 2014-08-21 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
EP2968288B1 (en) 2013-03-15 2018-07-04 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel
WO2015017305A1 (en) 2013-07-31 2015-02-05 Merck Sharp & Dohme Corp Inhibitors of the renal outer medullary potassium channel
EP3063142B1 (en) 2013-10-31 2019-01-30 Merck Sharp & Dohme Corp. Inhibitors of the renal outer medullary potassium channel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5822111B2 (ja) * 1977-10-29 1983-05-06 協和醗酵工業株式会社 柑橘類果実の改質剤
JPS63232846A (ja) * 1987-03-20 1988-09-28 Haruo Ogura 新規な固定相担体
WO1998022432A1 (en) * 1996-11-18 1998-05-28 Yamanouchi Pharmaceutical Co., Ltd. Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
US7030141B2 (en) * 2001-11-29 2006-04-18 Christopher Franklin Bigge Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade

Also Published As

Publication number Publication date
TW200500339A (en) 2005-01-01
JP2006522037A (ja) 2006-09-28
US20060211692A1 (en) 2006-09-21
US7504500B2 (en) 2009-03-17
DE10329457A1 (de) 2005-01-20
WO2004087695A1 (de) 2004-10-14
JP4634369B2 (ja) 2011-02-16
PE20050395A1 (es) 2005-06-04
BRPI0408888A (pt) 2006-04-11
AU2004226280A1 (en) 2004-10-14
EP1608646A1 (de) 2005-12-28
ES2287708T3 (es) 2007-12-16
KR20050118709A (ko) 2005-12-19
AU2004226280B2 (en) 2010-06-17
CA2520893A1 (en) 2004-10-14
PL377138A1 (pl) 2006-01-23
DE502004004294D1 (de) 2007-08-23
ATE366732T1 (de) 2007-08-15
CA2520893C (en) 2012-07-10
AR043831A1 (es) 2005-08-17
EP1608646B1 (de) 2007-07-11

Similar Documents

Publication Publication Date Title
MXPA05010433A (es) Derivados de pirrolidina y procedimiento para prepararlos.
MY142423A (en) Substituted aminoacetyl pyrrolidine compounds which are dipeptidyl peptidase iv inhibitors, and pharmaceutical compositions containing them
GEP20094679B (en) Dipeptidyl peptidase inhibitors
WO2004037181A3 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
WO2006005741A3 (en) Piperdine derivatives as renin inhibitors
ZA200604719B (en) DPP-IV inhibitors
GEP20094664B (en) Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
WO2004062613A3 (en) Hiv integrase inhibitors
TW200640920A (en) Salt of proline derivatives, its solvate and preparation method thereof
IL192253A0 (en) Substituted cyclohexylmethyl derivatives
MX2009004441A (es) Derivados de indazol utiles como inhibidores de las isoformas de higado.
TNSN05278A1 (en) Inhibitors of phosphatidylinositol 3-kinase
ATE381559T1 (de) Adamantan- und azabicyclooctan- und - nonanderivate, verfahren zu deren herstellung und deren verwendung als dpp-iv-inhibitoren
TW200607801A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
IL167434A (en) N-(substituted glycyl)-2,5-disubstituted pyrrolidines for use as inhibitors of dipeptidyl peptidase-iv (dpp-iv) and pharmaceutical compositions comprising the same
MXPA05013536A (es) Derivados de etinilprolina.
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
MY157871A (en) Mapk/erk kinase inhibitors
GEP20115166B (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
ZA200508888B (en) Methods for the production of pyrrolidine-1,2-dicarboxylic acid-1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carboxylic acid derivatives as intermediate products
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
PL1670778T3 (pl) Przegrupowane pentanole, sposób ich wytwarzania i ich zastosowanie jako środków hamujących zapalenia
TW200616958A (en) New alkyl-pyridines as 11-beta inhibitors for diabetes
GEP20104941B (en) Pyrrolopyridine-based inhibitors of dipeptidyl peptidase iv and methods
NO20076000L (no) Aminosyrederivater

Legal Events

Date Code Title Description
FA Abandonment or withdrawal